Modified Herpes Virus Shows Promise in Treating Advanced Melanoma
July 16th, 2025 2:05 PM
By: Newsworthy Staff
A clinical trial by USC researchers indicates that a genetically altered herpes virus could effectively combat certain forms of advanced melanoma, marking a significant step forward in cancer treatment research.
A recent study conducted by researchers from the University of Southern California’s Keck Medicine of USC has revealed that the herpes virus can be genetically modified to fight advanced melanoma. This clinical trial explored the potential of using an oncolytic virus, specifically a modified herpes virus, as a treatment for advanced skin cancers, showing promising results in the field of cancer therapy.
The research underscores the growing interest in oncolytic viruses as a viable treatment option for cancer, with companies like Calidi Biotherapeutics Inc. actively working on similar innovations. The findings from this study could pave the way for new, effective treatments for melanoma, a type of skin cancer that has been particularly challenging to treat in its advanced stages.
Source Statement
This news article relied primarily on a press release disributed by InvestorBrandNetwork (IBN). You can read the source press release here,
